Projecten per jaar
Vingerafdruk
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Projecten
- 1 Actief
-
FWOSB161: FORX – voedingsinterventies ter reductie van toxiciteit van immuuntherapie
1/11/23 → 31/10/27
Project: Fundamenteel
Onderzoeksoutput
-
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG)
Mac Eochagain, C., Neuendorff, N. R., Gente, K., Leipe, J., Verhaert, M., Sam, C., de Glas, N., Kadambi, S., Canin, B., Gomes, F., Decoster, L., Korc-Grodzicki, B., Rostoft, S., Battisti, N. M. L. & Wildiers, H., 4 feb 2025, In: Lancet Oncology. 26, 2, 13 blz.Onderzoeksoutput: Article › peer review
-
Trial in Progress (TiP): The FOod intervention trial to Reduce immunotherapy toXicity (FORX)
Aspeslagh, S., Demol, J., Demuyser, T., Adriaenssens, N. & Verhaert, M., 2025. 1 blz.Onderzoeksoutput: Poster
-
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
Verheijden, R. J., Burgers, F. H., Janssen, J. C., Putker, A. E., Veenstra, S. P. G. R., Hospers, G. A. P., Aarts, M. J. B., Hehenkamp, K. W., Doornebosch, V. L. E., Verhaert, M., van den Berkmortel, F. W. P. J., Chatzidionysiou, K., Llobell, A., Barros, M., Maria, A. T. J., Takeji, A., García Morillo, J-S., Lidar, M., van Eijs, M. J. M., Blank, C. U. & 9 anderen, , aug 2024, In: European Journal of Cancer. 207, 6 blz., 114172.Onderzoeksoutput: Article › peer review
Open AccessBestand9 Citaten (Scopus)3 Downloads (Pure) -
HCC Podcast Expert Series: Wat beïnvloedt, positief of negatief, het effect van immunotherapie?
Verhaert, M., 21 apr 2024Onderzoeksoutput: Digital or Visual Products
-
Immunosuppressive therapy management in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors: A case series and systematic literature review
Wuyts, S. C. M., Cappelle, C. A. H., Verhaert, M., Bravenboer, B. & Aspeslagh, S., 22 jan 2024, In: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 30, 1, blz. 55-66 12 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand1 Citaat (Scopus)48 Downloads (Pure)
Prijzen
-
First price - Best oral presentation of a junior clinical abstract at BSMO
Verhaert, Marthe (Recipient), 1 feb 2025
Prijs: Prize (including medals and awards)
-
FWO Travel grant to SITC conference
Verhaert, Marthe (Recipient), okt 2023
Prijs: Prize (including medals and awards)
Activiteiten
-
Journal club - intratumoraal microbioom
Marthe Verhaert (Speaker)
24 jan 2025Activiteit: Talk at a school event
-
Is immunotherapy an option in patients treated with immunosuppressive medication?
Marthe Verhaert (Speaker)
20 feb 2025Activiteit: Talk or presentation at a workshop/seminar
-
Three-year experience of the BITOX board
Marthe Verhaert (Speaker)
30 jan 2025Activiteit: Talk or presentation at a workshop/seminar
-
BSMO annual meeting
Marthe Verhaert (Chair)
25 feb 2025Activiteit: Participating in or organizing a public lecture/debate
-
Cardio-Oncology case
Marthe Verhaert (Speaker)
6 feb 2025Activiteit: Talk or presentation at a workshop/seminar
Knipsels
-
Delhaize Lunch & Learn: FORX-project
18/03/25
1 Mediabijdrage
Pers / media: !!Public Engagement Activities
-
-
Podcast Host Je Levensstijl als medicijn
Len De Nys, Andreas Delaere, Marthe Verhaert, Luc Colemont, Marie Beatrice D'Hooghe, Steven Laureys, Christel Fontaine & Julie Vanderlinden
19/03/21 → 5/03/25
16 Mediabijdrages
Pers / media: !!Public Engagement Activities
-
LifeMe podcast: Immuuntherapie en Darmgezondheid: Hoe Voeding de Behandeling van Kanker Beïnvloedt
9/11/24
1 Mediabijdrage
Pers / media: !!Public Engagement Activities
-
Scriptie
-
3-YEAR ANALYSIS OF THE BELGIAN MULTIDISCIPLINARY IMMUNOTOXICITY (BITOX) BOARD
Auteur: Aydogan, Y., Verhaert, M. & Aspeslagh, S., 10 jun 2024Scriptie/Masterproef: Master's Thesis
-
Pharmacological adaptations to immunosuppressive therapy in cancer patients with autoimmune diseases treated with immune checkpoint inhibitors
Auteur: Cappelle, C. A., Wuyts, S., Verhaert, M., Cortoos, P. & Aspeslagh, S., 2022Scriptie/Masterproef: Master-after-master